Cases & Deals

TissueTech raises capital in private placement to Ballast Point Ventures entities and River Cities Capital

Clients TissueTech, Inc.

Jones Day represented TissueTech, Inc., a provider of regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal, and wound care markets, in connection with its issuance of $10 million of Series A Preferred Stock in a private placement to Ballast Point Ventures II, L.P.; Ballast Point Ventures EF II, L.P.; and River Cities Capital Fund V, L.P.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.